According to an AGM resolution, the Nomination Committee 2022-2023 should consist of representatives of at least the three largest shareholders at the end of the third quarter of 2022 and the Chairman of the Board.
Work on composing the Nomination Committee is now completed, and this year's Nomination Committee consists of:
Karl Tobieson (Chairman), appointed by
The Annual General Meeting of
For further information, please contact:
Phone: +46 (0)8 5468 3100
E-mail: magnus.christensen@medivir.com
https://news.cision.com/medivir/r/nomination-committee-of-medivir-appointed,c3657299
https://mb.cision.com/Main/652/3657299/1645304.pdf
(c) 2022 Cision. All rights reserved., source